Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epigenetic regulation of somatostatin and somatostatin receptors in neuroendocrine tumors and other types of cancer
Maria J. Klomp, Simone U. Dalm, Marion de Jong, et al.
Reviews in Endocrine and Metabolic Disorders (2020) Vol. 22, Iss. 3, pp. 495-510
Open Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

The new WHO classification of gastrointestinal neuroendocrine tumors and immunohistochemical expression of somatostatin receptor 2 and 5
Oana Popa, Sorina Tãban, Stelian Pantea, et al.
Experimental and Therapeutic Medicine (2021) Vol. 22, Iss. 4
Open Access | Times Cited: 56
Role of Somatostatin Signalling in Neuroendocrine Tumours
Olesja Rogoza, Kaspars Megnis, Marija Kudrjavceva, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1447-1447
Open Access | Times Cited: 34
Alpha-peptide receptor radionuclide therapy using actinium-225 labeled somatostatin receptor agonists and antagonists
Mengqi Shi, Vivianne Jakobsson, Lukas Greifenstein, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 34
Neuroendocrine tumor theranostics
Yasushi Ichikawa, Noritoshi Kobayashi, Shoko Takano, et al.
Cancer Science (2022) Vol. 113, Iss. 6, pp. 1930-1938
Open Access | Times Cited: 30
Peptide Radioligands in Cancer Theranostics: Agonists and Antagonists
Berthold A. Nock, Panagiotis Kanellopoulos, Lieke Joosten, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 5, pp. 674-674
Open Access | Times Cited: 18
Peptide Conjugated Boron Neutron Capture Therapy for Enhanced Tumor Targeting
Vaskuri G. S. Sainaga Jyothi, Nagavendra Kommineni
Nanotheranostics (2024) Vol. 8, Iss. 4, pp. 458-472
Open Access | Times Cited: 7
Small molecule– and peptide–drug conjugates addressing integrins: A story of targeted cancer treatment
Jannik Paulus, Norbert Sewald
Journal of Peptide Science (2024) Vol. 30, Iss. 7
Open Access | Times Cited: 6
Peptide Receptor Radionuclide Therapy
Johannes Hofland, Tessa Brabander, Frederik A. Verburg, et al.
The Journal of Clinical Endocrinology & Metabolism (2022) Vol. 107, Iss. 12, pp. 3199-3208
Open Access | Times Cited: 26
Exploring the landscape of current in vitro and in vivo models and their relevance for targeted radionuclide theranostics
Lisa Bokhout, Joana D. Campeiro, Simone U. Dalm
European Journal of Nuclear Medicine and Molecular Imaging (2025)
Open Access
Methylation Profiles Differ According to Clinical Characteristics in Well-Differentiated Neuroendocrine Tumors of the Lung
Philipp Melhorn, Erwin Tomasich, Alissa Blessing, et al.
Endocrine Pathology (2025) Vol. 36, Iss. 1
Open Access
Heterogeneity of SSTR2 Expression Assessed by 68Ga-DOTATOC PET/CT Using Coefficient of Variation in Patients with Neuroendocrine Tumors
Rosa Fonti, Mariarosaria Panico, Sara Pellegrino, et al.
Journal of Nuclear Medicine (2022) Vol. 63, Iss. 10, pp. 1509-1514
Open Access | Times Cited: 19
Pancreatic Neuroendocrine Tumors: Signaling Pathways and Epigenetic Regulation
Zena Saleh, Matthew C. Moccia, Zachary Ladd, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1331-1331
Open Access | Times Cited: 4
The State-of-the-Art Mechanisms and Antitumor Effects of Somatostatin in Colorectal Cancer: A Review
Aldona Kasprzak, Agnieszka Geltz
Biomedicines (2024) Vol. 12, Iss. 3, pp. 578-578
Open Access | Times Cited: 4
Structure and Function of Somatostatin and Its Receptors in Endocrinology
Bo Zhang, Li Xue, Zhe Wu
Endocrine Reviews (2024) Vol. 46, Iss. 1, pp. 26-42
Open Access | Times Cited: 4
“Cold” Somatostatin Analogs in Neuroendocrine Neoplasms: Decoding Mechanisms, Overcoming Resistance, and Shaping the Future of Therapy
Sara Massironi, Manuela Albertelli, Iderina Hasballa, et al.
Cells (2025) Vol. 14, Iss. 4, pp. 245-245
Open Access
Characterizing SSTR2 expression and modulation for targeted imaging and therapy in preclinical models of triple-negative breast cancer
Shannon E. Lynch, Corinne L. Crawford, Hailey Houson, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Neuropeptides in Cancer: Friend and Foe?
Yue Wu, Adrian Berisha, Jeremy C. Borniger
Advanced Biology (2022) Vol. 6, Iss. 9
Closed Access | Times Cited: 16
Somatostatin Receptor 2 Expression Profiles and Their Correlation with the Efficacy of Somatostatin Analogues in Gastrointestinal Neuroendocrine Tumors
Hirofumi Watanabe, Fumiyoshi Fujishima, Izumi Komoto, et al.
Cancers (2022) Vol. 14, Iss. 3, pp. 775-775
Open Access | Times Cited: 15
Chemotherapy-Induced Upregulation of Somatostatin Receptor-2 Increases the Uptake and Efficacy of 177Lu-DOTA-Octreotate in Neuroendocrine Tumor Cells
Rashmi G. Shah, Marine A. Merlin, Samuel Adant, et al.
Cancers (2021) Vol. 13, Iss. 2, pp. 232-232
Open Access | Times Cited: 19
Octreotide attenuates intestinal barrier damage by maintaining basal autophagy in Caco2 cells
Xiaoli Liu, Yan Zhou, Yu Zhang, et al.
Molecular Medicine Reports (2024) Vol. 29, Iss. 6
Open Access | Times Cited: 2
Gastroenteropancreatic neuroendocrine tumors: Epigenetic landscape and clinical implications
Hannah Stowe McMurry, Jaydira Del Rivero, Emerson Y. Chen, et al.
Current Problems in Cancer (2024) Vol. 52, pp. 101131-101131
Closed Access | Times Cited: 2
Epigenetic-Like Stimulation of Receptor Expression in SSTR2 Transfected HEK293 Cells as a New Therapeutic Strategy
Joerg Kotzerke, Dorothee Buesser, Anne Naumann, et al.
Cancers (2022) Vol. 14, Iss. 10, pp. 2513-2513
Open Access | Times Cited: 12
Epigenetic Regulation in Gastroenteropancreatic Neuroendocrine Tumors
Judy S. Crabtree
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 12
Comparing the Effect of Multiple Histone Deacetylase Inhibitors on SSTR2 Expression and [111In]In-DOTATATE Uptake in NET Cells
Maria J. Klomp, Simone U. Dalm, Peter M. van Koetsveld, et al.
Cancers (2021) Vol. 13, Iss. 19, pp. 4905-4905
Open Access | Times Cited: 12
Somatostatin and Its Receptor System in Colorectal Cancer
Aldona Kasprzak
Biomedicines (2021) Vol. 9, Iss. 11, pp. 1743-1743
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top